52
Participants
Start Date
October 7, 2019
Primary Completion Date
April 7, 2024
Study Completion Date
April 7, 2024
AlloSure ddcfDNA assay
2.5 mL collection for Donor Derived Cell Free DNA at transplant, 3 weeks, 6 weeks, 6 months, 12 months post-transplant for Group A, at transplant for Group B, and transplant and 3 months for Group C
AlloMap assay
10 mL collection PAXgene blood sample at transplant, 3 weeks, 6 weeks, 6 months, 12 months post-transplant for Group A, at transplant for Group B, and transplant and 3 months for Group C
Inflammatory Cytokines
10 mL collection at transplant, 3 weeks, 6 weeks, 6 months, 12 months post-transplant for Group A
Immune Cell Phenotypes
Collection of up to 1 cup of urine for per participant each study visit
University of Wisconsin - Madison, Madison
Collaborators (1)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
CareDx
INDUSTRY
University of Wisconsin, Madison
OTHER